Loading…
Based on limited metadata, Cerno Pharmaceutical received an FDA Warning Letter on May 15, 2018, regarding an unspecified product category. Without access to the full letter text or subject line details, the specific nature of the violations cannot be determined from the available information. The issuing office is also not documented in this metadata. To understand the regulatory concerns and required corrective actions, the complete Warning Letter would need to be reviewed.